What is Pre-Implantation Genetic Screening?

Pre-Implantation Genetic Screening (PGS) is a state-of-the-art technology that allows for the detection of chromosomal abnormalities in embryos before they are implanted into the uterus. This advanced fertility treatment option is used to improve the chances of a successful pregnancy and the health of the resulting child.

During in vitro fertilization (IVF), embryos are created in a laboratory and then screened for chromosomal abnormalities using PGS. Only healthy embryos are chosen for implantation, increasing the chances of a successful pregnancy.

PGS can be used to screen for a wide range of chromosomal abnormalities, including aneuploidies (an abnormal number of chromosomes) and structural chromosomal abnormalities. This technology can also be used to identify embryos that are most likely to be viable, which can be especially beneficial for couples who have had multiple failed IVF cycles or for women who are at risk of miscarriage.

PGS is a safe and reliable technology that is performed by a team of experienced fertility specialists. The procedure is performed in conjunction with IVF and involves a small biopsy of the embryonic cells. The cells are then analyzed for chromosomal abnormalities using advanced genetic testing techniques.

For couples who are considering PGS, it is important to work with a fertility specialist who is experienced in the latest genetic testing technologies and who can provide personalized care and support.